Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $37.3300 (0.03%) ($37.0500 - $37.6350) on Wed. Sep. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.6% (three month average) | RSI | 30 | Latest Price | $37.3300(0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.6% a day on average for past five trading days. | Weekly Trend | BAX declines -1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) EWJ(98%) SPLV(88%) SLV(87%) ACES(79%) EWY(70%) | Factors Impacting BAX price | BAX will decline at least -0.8% in a week (0% probabilities). KWEB(-34%) URA(32%) XOP(-22%) IDRV(-13%) XLU(27%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.8% (StdDev 1.6%) | Hourly BBV | -0.1 () | Intraday Trend | -0.2% | | | |
|
1 - 5 Day Possible Target | $32.65(-12.54%) | Resistance Level | $38.83 | 5 Day Moving Average | $37.59(-0.69%) | 10 Day Moving Average | $38.19(-2.25%) | 20 Day Moving Average | $38.83(-3.86%) | To recent high | -24.3% | To recent low | 0% | Market Cap | $19.045b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |